Determination of a Normal Level of Serum CA125 in Postmenopausal Women as a Tool for Preoperative Evaluation and Postoperative Surveillance of Endometrial Carcinoma
Authors:
- Hideki MizunumaHMHideki Mizunuma
- Mitsuo ObaraMOMitsuo Obara
- Kazumichi AndohKAKazumichi Andoh
- Yoshito IbukiYIYoshito Ibuki
- Toshinobu NishimuraTNToshinobu Nishimura
- 1 June 1998
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 69 (3) , 192-196
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- What Is a Normal CA125 Level?Gynecologic Oncology, 1994
- The effect of the menstrual cycle on serum CA 125 levels: A population studyAmerican Journal of Obstetrics and Gynecology, 1992
- Does serum CA-125 level prior to second-look laparotomy for invasive ovarian adenocarcinoma predict size of residual disease?Gynecologic Oncology, 1990
- Prospective evaluation of serum CA 125 levels in a normal population, phase I: The specificities of single and serial determinations in testing for ovarian cancerGynecologic Oncology, 1990
- Serum CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1989
- CA 125: A useful marker in endometrial carcinomaAmerican Journal of Obstetrics and Gynecology, 1986
- The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1986
- Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervixAmerican Journal of Obstetrics and Gynecology, 1984
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981